Your search returned 2459 results.

Results
	2101.	Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response. [electronic resource] by Li, Zhiguo Li, Jie Kong, Yifan Yan, Shan Ahmad, Nihal Liu, Xiaoqi Producer: 20170914 In: Cancer research vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2102.	Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study. [electronic resource] by Lee, Jung-Min Cimino-Mathews, Ashley Peer, Cody J Zimmer, Alexandra Lipkowitz, Stanley Annunziata, Christina M Cao, Liang Harrell, Maria I Swisher, Elizabeth M Houston, Nicole Botesteanu, Dana-Adriana Taube, Janis M Thompson, Elizabeth Ogurtsova, Aleksandra Xu, Haiying Nguyen, Jeffers Ho, Tony W Figg, William D Kohn, Elise C Producer: 20170825 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2103.	Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors. [electronic resource] by Jdey, Wael Thierry, Sylvain Russo, Christophe Devun, Flavien Al Abo, Muthana Noguiez-Hellin, Patricia Sun, Jian-Sheng Barillot, Emmanuel Zinovyev, Andrei Kuperstein, Inna Pommier, Yves Dutreix, Marie Producer: 20180213 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2104.	Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition. [electronic resource] by Murai, Junko Feng, Ying Yu, Guoying K Ru, Yuanbin Tang, Sai-Wen Shen, Yuqiao Pommier, Yves Producer: 20180226 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2105.	A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. [electronic resource] by Pratt, Guy Yap, Christina Oldreive, Ceri Slade, Daniel Bishop, Rebecca Griffiths, Mike Dyer, Martin J S Fegan, Chris Oscier, David Pettitt, Andrew Matutes, Estella Devereux, Stephen Allsup, David Bloor, Adrian Hillmen, Peter Follows, George Rule, Simon Moss, Paul Stankovic, Tatjana Producer: 20190607 In: British journal of haematology vol. 182 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2106.	PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors. [electronic resource] by Parsels, Leslie A Karnak, David Parsels, Joshua D Zhang, Qiang Vélez-Padilla, Jonathan Reichert, Zachery R Wahl, Daniel R Maybaum, Jonathan O'Connor, Mark J Lawrence, Theodore S Morgan, Meredith A Producer: 20190111 In: Molecular cancer research : MCR vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2107.	New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease. [electronic resource] by Jalili-Baleh, Leili Nadri, Hamid Moradi, Alireza Bukhari, Syed Nasir Abbas Shakibaie, Mojtaba Jafari, Mandana Golshani, Mostafa Homayouni Moghadam, Farshad Firoozpour, Loghman Asadipour, Ali Emami, Saeed Khoobi, Mehdi Foroumadi, Alireza Producer: 20171018 In: European journal of medicinal chemistry vol. 139 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2108.	Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency. [electronic resource] by Yang, Lin Yang, Guanghai Ding, Yingjun Huang, Yu Liu, Shunfang Zhou, Lei Wei, Wenjie Wang, Jing Hu, Guangyuan Producer: 20180927 In: Oncology reports vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2109.	Non-small cell lung cancer cells with deficiencies in homologous recombination genes are sensitive to PARP inhibitors. [electronic resource] by Ji, Wenchao Weng, Xiang Xu, Danhua Cai, Shufan Lou, Honggang Ding, Ling Producer: 20200819 In: Biochemical and biophysical research communications vol. 522 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2110.	Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells. [electronic resource] by Mani, Chinnadurai Jonnalagadda, Shirisha Lingareddy, Jojireddy Awasthi, Sanjay Gmeiner, William H Palle, Komaraiah Producer: 20200226 In: Breast cancer research : BCR vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2111.	PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer. [electronic resource] by Jin, Xin Fang, Rui Fan, Ping Zeng, Lipeng Zhang, Bin Lu, Xiaoming Liu, Tao Producer: 20200515 In: Journal of experimental & clinical cancer research : CR vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2112.	Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling. [electronic resource] by Zhao, Jie Sun, Yin Lin, Hui Chou, Fuju Xiao, Yao Jin, Ren'an Cai, Xiujun Chang, Chawnshang Producer: 20210119 In: FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2113.	Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. [electronic resource] by Williamson, Chris T Kubota, Eiji Hamill, Jeffrey D Klimowicz, Alexander Ye, Ruiqiong Muzik, Huong Dean, Michelle Tu, LiRen Gilley, David Magliocco, Anthony M McKay, Bruce C Bebb, D Gwyn Lees-Miller, Susan P Producer: 20120928 In: EMBO molecular medicine vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2114.	The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials. [electronic resource] by Vitfell-Pedersen, J Yap, T A Moreno, V Baird, R D Khan, A Z Barton, D P J Kaye, S B Producer: 20120625 In: European journal of gynaecological oncology vol. 33 Availability: No items available. Save to lists Add to cart (remove)
	2115.	Indolinones and anilinophthalazines differentially target VEGF-A- and basic fibroblast growth factor-mediated responses in primary human endothelial cells. [electronic resource] by Latham, A M Bruns, A F Kankanala, J Johnson, A P Fishwick, C W G Homer-Vanniasinkam, S Ponnambalam, S Producer: 20120605 In: British journal of pharmacology vol. 165 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2116.	AMG 900, a small-molecule inhibitor of aurora kinases, potentiates the activity of microtubule-targeting agents in human metastatic breast cancer models. [electronic resource] by Bush, Tammy L Payton, Marc Heller, Scott Chung, Grace Hanestad, Kelly Rottman, James B Loberg, Robert Friberg, Gregory Kendall, Richard L Saffran, Douglas Radinsky, Robert Producer: 20140707 In: Molecular cancer therapeutics vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2117.	Co-treatment with BEZ235 Enhances Sensitivity of BRCA1-negative Breast Cancer Cells to Olaparib. [electronic resource] by Yi, Yong Weon Park, Jeong-Soo Kwak, Sahng-June Seong, Yeon-Sun Producer: 20150922 In: Anticancer research vol. 35 Availability: No items available. Save to lists Add to cart (remove)
	2118.	A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair. [electronic resource] by Parrotta, Rossella Okonska, Agata Ronner, Manuel Weder, Walter Stahel, Rolf Penengo, Lorenza Felley-Bosco, Emanuela Producer: 20180420 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2119.	USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response. [electronic resource] by Li, Yunhui Luo, Kuntian Yin, Yujiao Wu, Chenming Deng, Min Li, Lei Chen, Yuping Nowsheen, Somaira Lou, Zhenkun Yuan, Jian Producer: 20181218 In: Nature communications vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2120.	ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair. [electronic resource] by Chen, Chun-Chin Kass, Elizabeth M Yen, Wei-Feng Ludwig, Thomas Moynahan, Mary Ellen Chaudhuri, Jayanta Jasin, Maria Producer: 20180608 In: Proceedings of the National Academy of Sciences of the United States of America vol. 114 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 2459 results.